MXPA04001128A - Method for identifying substances which positively influence inflammatory conditions. - Google Patents

Method for identifying substances which positively influence inflammatory conditions.

Info

Publication number
MXPA04001128A
MXPA04001128A MXPA04001128A MXPA04001128A MXPA04001128A MX PA04001128 A MXPA04001128 A MX PA04001128A MX PA04001128 A MXPA04001128 A MX PA04001128A MX PA04001128 A MXPA04001128 A MX PA04001128A MX PA04001128 A MXPA04001128 A MX PA04001128A
Authority
MX
Mexico
Prior art keywords
positively influence
inflammatory conditions
identifying substances
influence inflammatory
nhr
Prior art date
Application number
MXPA04001128A
Other languages
Spanish (es)
Inventor
Jung Birgit
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA04001128A publication Critical patent/MXPA04001128A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to NHR-proteins involved in inflammatory processes and the modulation of the function of such a NHR-protein in order to positively influence inflammatory diseases.
MXPA04001128A 2001-08-06 2002-07-17 Method for identifying substances which positively influence inflammatory conditions. MXPA04001128A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01119003 2001-08-06
PCT/EP2002/007937 WO2003014745A2 (en) 2001-08-06 2002-07-17 Method for identifying anti-inflammatory drugs

Publications (1)

Publication Number Publication Date
MXPA04001128A true MXPA04001128A (en) 2004-05-20

Family

ID=8178260

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001128A MXPA04001128A (en) 2001-08-06 2002-07-17 Method for identifying substances which positively influence inflammatory conditions.

Country Status (6)

Country Link
EP (1) EP1425587A2 (en)
JP (1) JP2005503787A (en)
AU (1) AU2002321229A1 (en)
CA (1) CA2453913A1 (en)
MX (1) MXPA04001128A (en)
WO (1) WO2003014745A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005074969A2 (en) * 2004-02-07 2005-08-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a1 (nr4a1)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024471A1 (en) * 1997-11-10 1999-05-20 The Research Foundation Of State University Of New York Opiate, cannabinoid, and estrogen receptors
KR20020010581A (en) * 1999-03-11 2002-02-04 사단호진 산교 소죠켄큐쇼 Novel ligands of nuclear receptors ppar's
CA2284103A1 (en) * 1999-09-30 2001-03-30 Edith Bonnelye Estrogen related receptor, err.alpha., a regulator of bone formation
MXPA03004797A (en) * 2000-12-22 2004-12-03 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases.
CA2430610A1 (en) * 2000-12-22 2002-07-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Also Published As

Publication number Publication date
EP1425587A2 (en) 2004-06-09
JP2005503787A (en) 2005-02-10
WO2003014745A2 (en) 2003-02-20
CA2453913A1 (en) 2003-02-20
WO2003014745A3 (en) 2004-03-25
AU2002321229A1 (en) 2003-02-24

Similar Documents

Publication Publication Date Title
DE60234464D1 (en) Compositions and methods for selective nucleic acid isolation
DE69918089D1 (en) BTK INHIBITORS AND METHOD FOR IDENTIFICATION AND USE
DE60131262D1 (en) Ubiquitin-ligase-assay
ATE520466T1 (en) APPARATUS AND METHOD FOR MODIFYING MAGNETICALLY IMMOBILIZED BIOMOLECULES
WO2002030353A3 (en) NF-λB INHIBITORS
WO2002097130A3 (en) Microstructures and use thereof for the directed evolution of biomolecules
PL1702066T3 (en) Method and device for purifying nucleic acids
DE50113396D1 (en) System for the targeted deformation of optical elements
ATE458191T1 (en) METHOD FOR SELECTING PARTICLES
ES2162277T3 (en) SUBSTRATES AND INHIBITORS OF PROTEOLITIC ENZYMES.
WO2001075178A3 (en) Methods for identifying peptide aptamers capable of altering a cell phenotype
DE60224275D1 (en) MOLECULES AND METHOD FOR INHIBITING THE RELEASE OF KIM-1
FI20011353A (en) Method and apparatus for clarifying and / or thickening the sludge
MXPA03007413A (en) Composition and method for treating inflammatory disorders.
CA2418506A1 (en) Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
AU2002364914A8 (en) Computer-implemented system and method for productivity enhancement
NO20033921L (en) Monoamine uptake inhibitor
MXPA04001128A (en) Method for identifying substances which positively influence inflammatory conditions.
WO2002061430A3 (en) Methods and reagents for treating autoimmune disorders
MXPA03006828A (en) System and method for cleaning and/or treating vehicle surfaces.
WO2002052269A3 (en) Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
MXPA03005400A (en) Method for the preparation of 11(12)-pentadecen-15-olides.
DE50201084D1 (en) Process for the hydrogenation of unsaturated transition metal compounds
WO2003031584A3 (en) Axon repair
WO2002052036A3 (en) Identification of modulators of dham-kinase and inflammatory diseases

Legal Events

Date Code Title Description
FA Abandonment or withdrawal